Abnormalities, Drug-Induced
Research News and Information

Monday, November 23, 2009

[Anticoagulation during pregnancy following an artificial heart valve replacement]

4 Oct 2009 HISTORY AND CLINICAL FINDINGS: A 23-year-old woman had received a mechanical bileaflet mitral valve prosthesis because of severe mitral valve insufficiency caused by an acute bacterial endocarditis with vegetations. One year after the operation the ... Read more...

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.

21 Sep 2009 OBJECTIVE: To investigate any association between selective serotonin reuptake inhibitors (SSRIs) taken during pregnancy and congenital major malformations. DESIGN: Population based cohort study. PARTICIPANTS: 493 113 children born in Denmark, ... Read more...

Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.

13 Sep 2009 BACKGROUND: In the context of the increasing resistance to sulfadoxine-pyrimethamine (SP), we evaluated the efficacy of mefloquine (MQ) for intermittent preventive treatment during pregnancy (IPTp). METHODS: A multicenter, open-label equivalence ... Read more...

Latest indexed articles for 'Abnormalities, Drug-Induced'

These are the very latest articles for this heading:

• SSRIs and congenital defects. Spontaneous publishing and academic miscarriages (SPAM). 19 Oct 2009
• Women should give informed consent before starting SSRIs. 19 Oct 2009
• SSRIs and heart defects in neonates. 19 Oct 2009
• SSRIs and congenital defects. Case registers in pregnancy? 19 Oct 2009
• GSK is sued in US over alleged link of paroxetine to birth defects. 10 Oct 2009
• [Anticoagulation during pregnancy following an artificial heart valve replacement] 4 Oct 2009
• Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. 21 Sep 2009
• Selective serotonin reuptake inhibitors and congenital malformations. 21 Sep 2009
• Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. 13 Sep 2009
• The impact of human superoxide dismutase 1 expression in a mouse model on the embryotoxicity of hydroxyurea. 30 Aug 2009
• Genetic and environmental factors in the etiology of esophageal atresia and/or tracheoesophageal fistula: an overview of the current concepts. 30 Aug 2009
• Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy? 30 Aug 2009
• Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: the use of a disaster epidemiological model for the evaluation of drug teratogenicity. 30 Aug 2009
• Pregnancy treatment guidelines: throwing the baby out with the bath water. 30 Aug 2009
• An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. 30 Jul 2009
• Atypical antipsychotic (clozapine) self-poisoning in late pregnancy presenting with absent fetal heart rate variability without acidosis and delayed peristalsis in the newborn baby: a case report. 30 Jul 2009
• Effect of prenatal tetrandrine administration on transforming growth factor-beta1 level in the lung of nitrofen-induced congenital diaphragmatic hernia rat model. 30 Jul 2009
• Isolated corneal opacification and microphthalmia: a suspected warfarin embryopathy. 30 Jul 2009
• Lopinavir/ritonavir in pregnancy. 30 Jul 2009
• [Progesterone-estradiol benzoate combination (Duogynon)--a retrospective contemplation] 21 Jul 2009

See a longer list of these articles.

Technical information about 'Abnormalities, Drug-Induced'

Definition: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.

Descriptor UI: D000014

Alternative terms: Abnormalities, Drug-Induced; Abnormalities, Drug Induced; Drug-Induced Abnormalities; Abnormality, Drug-Induced; Drug Induced Abnormalities; Drug-Induced Abnormality;

Related Mesh Headings: Teratogens;

Allowable Qualifiers: blood; cerebrospinal fluid; classification; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; virology;

Tree Number: C16.131.042;

History Note: 64

Technical Notes: IM; do not use /chem ind /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific chem /adv eff-pois-tox (IM) + specific organ /abnorm or specific abnorm /chem ind (IM); Manual 23.20.3